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Abstract
BACKGROUND: With the epidemic of diabetes mellitus projected to rise from 1 in 10 U.S.
adults (year 2010) to 1 in 3 by the year 2050, there is a need for health care organizations to
prepare nurses to manage the complexity of meeting the needs of patients with diabetes,
especially in the timely administration of subcutaneous insulin. The traditionally accepted
practice of double-checking subcutaneous insulin before administration, albeit non-evidencebased, poses a clinical problem by imposing an unnecessary demand on nurses’ workload, which
places an obstacle to their timely administration of time-critical subcutaneous insulin.
PURPOSE: This project aimed to examine if there would be a difference in medication errors
surrounding nurses’ subcutaneous insulin administration when their system is altered from an
independent double-checking to a single-checking environment. METHODS: This quasiexperimental project was composed of a two-phase pilot study, with the first (double-checking)
acting as the control and the second (single-checking) acting as the interventional phase.
RESULTS: Over a seven-week period, there were a total of 1,528 opportunities for
subcutaneous insulin administration and omission in both phases among the 92 patients included
in the sample. There was no significant difference in the “any one error” rates between the
double-checking and single-checking phases. Of administration error types, “wrong-time” was
predominant and more prevalent during the double-checking phase, which took an average of
11.7 minutes longer. CONCLUSIONS: The traditional double-checking process did not
significantly reduce medication error rates and contributed to a longer time lapse from blood
glucose check to insulin administration.
Keywords: double-checking, subcutaneous insulin, medication errors, high-reliability
organizations
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Chapter 1
Introduction
The Institute for Safe Medication Practices (ISMP), a non-profit organization dedicated
to eradicate medication errors by educating practitioners and consumers about safe medication
practices, conducted a study from 1995 to 1996 that identified insulin as one of the “top five”

high-alert medications (Cohen, Proulx, & Crawford, 1998). High-alert medications (HAMs) are
drugs that carry the highest risk of causing serious patient injury when misused (Cohen &
American Pharmaceutical Association [APhA], 1999). In 1999, The Joint Commission (TJC)
issued an alert that cited the study’s top five “high-alert medications” and listed common risk
factors that contributed to related medication errors (The Joint Commission, 1999).
Furthermore, TJC suggested strategies to reduce the potential for errors related to these top five
high-alert medications. For three of the five high-alert medications, insulin included, TJC
suggested the use of independent double-checks (IDC). This publication was the earliest
mention in the literature of a national healthcare organization-accrediting body suggesting the
use of an IDC to reduce insulin-related medication errors.
In addition to TJC’s publication, the Institute for Safe Medication Practices (ISMP) later
published a more comprehensive list of high-alert medications (Institute for Safe Medication
Practices [ISMP], 2003). ISMP’s goal in compiling and publishing this list was to encourage
practitioners and healthcare institutions to determine what medications for which they needed to
develop special risk-reducing strategies. The list, which was periodically updated, was based on
data that the ISMP collected from its National Medication Errors Reporting Program (MERP).
The list identified common harmful medication errors in the literature, drugs reported by
practitioners in a survey related to errors at their facilities, and included input from medication
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safety experts. More recently, the list has since included both subcutaneous and intravenous (IV)
forms of insulin, with special emphasis on the frequently misused U-500, which is a highly
concentrated solution of insulin that consists of 500 units/mL in comparison to the standard 100
units/mL (U-100) concentration (ISMP, 2014). Even though ISMP cited the use of IDC as one
of the strategies to safeguard against high-alert medication errors, it also provided the caveat that
“manual double checks are not always the optimal error reduction strategy and may not be
practical for a few of the medications on the list” (ISMP, 2003; ISMP, 2007; ISMP 2012; ISMP
2014).
However, in response to the suggestions of these two nationally recognized organizations
and TJC’s high-alert medication management accreditation standard (MM.01.01.03), some
healthcare institutions began requiring the use of IDC prior to administration of a select few
high-alert medications. For example, an acute care hospital in southern California required the
use of an IDC prior to subcutaneous administration of standard concentration (U-100) insulin to
adults but not prior to IV administration of metoprolol and labetalol use, which have also been in
ISMP’s high-alert medication list for as long as subcutaneous insulin has been (ISMP, 2003;
ISMP, 2007; ISMP 2012; ISMP 2014).
Statement of the Problem
In theory, IDC processes were proposed by ISMP and TJC to reduce serious medication
errors, especially overdosing and wrong-preparation errors (Cohen et al., 1998; The Joint
Commission, 1999). However, there is limited evidence on whether IDC processes are effective
in reducing these types of medication errors, especially with subcutaneous insulin.
Furthermore, the ISMP declared rapid-acting insulins, such as insulin aspart
(NovoLog®), as a time-critical scheduled medication (ISMP, 2011). Time-critical scheduled
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medications are those where early or delayed administration of greater than 30 minutes before or
after the scheduled time may result in harm or significant sub-therapeutic or pharmacological
effect (ISMP, 2011). However, adult patients who are scheduled to receive subcutaneous insulin
often do not receive their dose within 30 minutes of the scheduled dose (Modic et al., 2016).
With the number of patients with diabetes on the rise, delayed administration of insulin could
lead to poorer patient care outcomes.
Background and Significance
Diabetes mellitus has become an epidemic in the United States. The Centers for Disease
Control and Prevention (CDC) reports that from 1980 through 2014, the number of U.S. adults
aged 18 years or older who were diagnosed with diabetes increased fourfold, from 5.5 million to
21.9 million (CDC, 2015). As of 2010, the prevalence of diabetes in the U.S. was about 1 in 10
adults but it was projected that if the same trend were to continue (due to an aging population,
increase in lifespan, and increase in at-risk minority groups), its prevalence would be as many as
1 in 3 U.S. adults by the year 2050 (Boyle, Thompson, Gregg, Barker, & Williamson, 2010).
This projected rise in the prevalence of adults with diabetes could reflect an increase in the
number of patients who would need subcutaneous insulin during hospitalization. Consequently,
this could further increase the subcutaneous insulin-related workload of nurses.
The current subcutaneous insulin-related workload of nurses usually involves an
independent double-checking process, a process that could take an average of 5 minutes (Modic
et al., 2016). This can be a burden for the nurse responsible for the administration of the insulin
as well as the nurse called upon to assist with the double-checking method. A requirement
placed on nurses to perform an independent double-check prior to routine subcutaneous insulin
administration means that the primary nurse, for instance, would need to find another nurse, and
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interrupt that nurse’s workflow. This second nurse is required to independently look at the
insulin sliding scale, calculate the correct dose, and compare the electronic medication
administration record (eMAR) to the medication.
Add into this scenario that the primary nurse may also be the one who is responsible to
check the blood sugar (the nurse aide may not have the competency), may be in personal
protective equipment (PPE) in an isolation room with no immediate access to a second nurse, or
may have other patients with subcutaneous insulin needs during the same time period.
Inconsistent patient meal delivery times may also add to the complexity of coordinating the
timely administration of insulin. The nurse may go through this process for up to three times for
each insulin-needing patient in a 12-hour day shift. Therefore, requiring nurses to perform an
IDC prior to subcutaneous insulin administration may pose as an obstacle to the timely
administration of a time-critical medication, such as subcutaneous rapid-acting insulin.
Significance of the Project to Nursing
The aim of this study was to investigate whether the current practice (of requiring an
independent double-check prior to subcutaneous insulin administration) is still consistent with
most current evidence. It must be noted that there is limited literature on the effectiveness of
IDC in reducing subcutaneous insulin-related medication errors. A systematic review of the
literature concluded that there is no sufficient evidence to either uphold or contest the
effectiveness of IDC in reducing medication errors (Alsulami, Conroy, & Choonara, 2012).
Specific to insulin, a recent study concluded that though the use of IDC prior to subcutaneous
insulin administration was effective in reducing omission errors, it was not effective in reducing
either wrong-preparation or wrong-dose errors (Modic et al., 2016), which are errors that The
Joint Commission theorized an IDC would reduce (The Joint Commission, 1999).
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Furthermore, the ISMP explicitly expressed that “the overuse of the independent doublecheck for the high volume of subcutaneous insulin doses is detrimental [emphasis added] to the
effective use of this mid-level process with other more important high-alert medications” (G.
Banasser, personal communication, January 16, 2017). Therefore, with this evidence-based
practice project’s provision, practitioners and hospital policymakers can appraise additional
evidence and decide if an IDC should continue to be required prior to subcutaneous insulin
administration to its patient population. This project may further contribute to the developing
body of knowledge on this topic and could offer a reproducible model and recommendations for
future studies.
Project Model and Theoretical Framework
This project was based on a model to guide its progress and on a theoretical framework to
explain the risks of the overuse of independent double-check processes in preventing errors
related to high-frequency tasks, such as subcutaneous insulin administration.
Iowa model. The conceptual model of this project was the Iowa Model of EvidenceBased Practice to Promote Quality of Care (Titler et al., 2001). The purpose of this model (see
Appendix A) is to guide the direction for evidence-based practice (EBP) development in a
clinical institution, such as a hospital. This model poses that there are knowledge-focused
triggers and problem-focused triggers that spark the need for change. For this project,
knowledge-focused triggers included new study findings and national organizational guidelines
while a problem-focused trigger was derived from the identification of a clinical problem.
As previously mentioned, there is limited literature on the effectiveness of IDC in
reducing subcutaneous insulin-related medication errors. Of what is available, there is not
adequate evidence that supports or refutes the effectiveness of the use of IDC in reducing
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subcutaneous insulin-medication errors (Modic et al., 2016). Furthermore, the nationally
recognized medication safety authority, ISMP, explicitly recommends against it when used prior
to standard concentration (U-100) subcutaneous insulin administration (G. Banasser, personal
communication, January 16, 2017). Therefore, this traditionally supported practice, albeit nonevidence-based, poses a clinical problem by placing an unnecessary demand on nursing
workload and is an obstacle to the timely administration of subcutaneous insulin. This may
induce financial loss to the hospital due to reduced nursing productivity secondary to an
inefficient patient care flow process and nurse overtime wages. This may also lead to wrongtime (late) medication administration errors that may place patients at risk for hypoglycemia,
which is seen in insulin stacking—the practice of administering additional doses of insulin
before a previous dose of insulin has had its full effect (Heise & Meneghini, 2014). These
factors make this issue a priority for health care organizations.
Once a topic is considered a priority for the organization, the Iowa Model also provides
steps to follow. Steps include forming of a team to assemble relevant literature in order to
critique and synthesize evidence for use in practice. Once synthesized, the project team pilots
the change on select units. Outcomes to be achieved are selected, baseline data are collected,
and EBP guidelines are designed and implemented. Later in the pilot study, the process and
outcomes are reviewed and evaluated. As a result of evaluation, the practice guideline is
modified. Once the pilot study is completed, if stakeholders deem that the change is appropriate
for adoption into practice, the change is implemented hospital-wide. Outcome data are then
monitored and analyzed to determine the impact of the change on the hospital’s staff, costs, and
patients, ensuring the promotion of optimal patient care outcomes.
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Human error theory. Since this project’s interest was on whether double-checking
causes a significant change in the incidence of medication errors, it was fitting to form a
knowledge base of the theories behind what is thought to cause errors and how to properly
address them. This section examines the more encompassing human error theory. Chapter 2
will further explain this theory’s relationship to high-reliability theory (HRT) and normal
accident theory (NAT).
Human error theory poses that human errors can be approached in two ways: (a) the
person approach and (b) the system approach (Reason, 2000). Adherents of the person approach
focus on the front-line people who err, holding to the belief that errors arise due to a person’s
carelessness, inattention, and incapacity to prevent the error. The proposed countermeasures
appeal to people’s sense of fear through disciplinary measures such as blaming and shaming, or
threat of litigation as means to reduce the unwanted component of human behavior.
In contrast, the system approach holds that to err is naturally human and that “errors are
to be expected, even in the best organizations” (Reason, 2000, p. 768). System approach
proponents focus on controlling the conditions (systems) under which the error occurred/could
potentially occur. The proposed countermeasures are based on the premise that “though we
cannot change the human condition, we can change the conditions under which humans work”
(Reason, 2000, p. 768). This system approach attempts to maximize the system barriers in order
to minimize error-provoking conditions in the front-line workplace (e.g., time pressure, fatigue,
understaffing, inadequate resources in light of increased workload).
Purpose/Goal of the Project
Specific to this project, the more endorsable system approach can be applied in an
attempt to influence the system by reducing the time pressure on nurses through altering their
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system from an independent double-checking to a single-checking environment prior to
performing a high-frequency task, such as subcutaneous insulin administration. This study
implemented a single-checking intervention to determine differences in medication errors
between the double-checking and single-checking method and hence was an investigation into
what factors could relieve unnecessary nurse workload and lead to a decrease in their errors.
Study Questions
This study aimed to answer two questions: (1) Is there a significant difference in the
number of subcutaneous insulin-related medication errors in adult patients who receive
subcutaneous insulin without an independent double-check as compared to the number of
subcutaneous insulin-related medication errors in adult patients who receive subcutaneous
insulin after an independent double-check? and (2) Is there a relationship between select
variables and the occurrence of a medication error?
Definitions of Terms
For the purposes of this thesis project the following terms are defined:
Medication error. “Any error occurring in the medication use process” (Bates, Boyle,
Vander Vliet, Schneider, & Leape, 1995). Specifically, for this project, it involves any of the
following four categories of errors in the administration phase: wrong-time, wrong dose,
inappropriate omission, or wrong-preparation of subcutaneous insulin administration. Wrongdose errors are further subcategorized into over-dosing and under-dosing errors.
Wrong-time error. Modic et al. (2016) defined a wrong-time error as “an insulin
administration deviation greater than 30 minutes after blood glucose point-of-care testing, as the
device downloaded results immediately to the electronic medical record [EMR]” (p. 156).

INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN

9

Because the facility that was used in this study allows for the results of blood glucose point-ofcare testing to be downloaded immediately to the EMR, this definition was maintained.
Independent double-check (IDC). “An independent double-check requires two people
to separately check each component of the work process” (ISMP, 2013). For this project, the
IDC process necessitated the primary nurse to calculate an insulin dose, prepare the insulin pen,
and compare the product to the actual order. Afterwards, a second nurse independently
(separately) checked the order with the MAR, calculated the dose, and then compared the
primary nurse’s results with the dispensed product for verification. Only after completing this
double-checking process was the primary nurse allowed to administer an insulin dose.
Single-checking. For this project, single-checking meant that the primary nurse was
allowed to administer an insulin dose without double-checking with a second nurse.
Summary
This chapter defined the problem and addressed the principal research question: “In adult
patients who receive subcutaneous insulin, how does implementing single-checking as compared
to independent double-checking affect medication errors?” The background and significance of
the problem were also addressed, given the limited evidence, and the Iowa Model was proposed
to guide the study’s progress towards promoting evidence-based practice of insulin
administration in the acute care hospital setting. This chapter also provided an exploration of the
theory behind the principal investigator’s hypothesis that reducing nurse workload (by switching
to a single-checking culture prior to such a high-frequency task as subcutaneous insulin
administration) may improve patient outcomes by reducing medication errors. This chapter also
listed key terms and presented landmark research studies on this topic as well as position
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statements by medication safety advocate groups. The next chapter further explores the current
evidence on this topic.
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Chapter 2
Literature Review
In recent decades, the independent double-checking (IDC) prior to subcutaneous insulin
administration has been the gold standard of practice in reducing insulin-related medication
errors among adults. The effectiveness of this process has come into question in light of there
being no evidence to support the notion that the traditional nursing practice of IDC reduces
subcutaneous insulin-related medication errors. Some well-known hospital consortiums that
include acute care hospitals operating in multiple states do not require IDC prior to subcutaneous
insulin administration (Kaiser Foundation Hospital/Southern California Permanente Medical
Group [KFH/SCPMG], 2006).
Online Poll
In an effort to identify which Southern California healthcare settings do not require RNs
to perform an IDC prior to subcutaneous insulin administration in adults, the principal
investigator (PI) conducted an informal online poll of previous nursing (RN) school classmates
and RN coworkers through Facebook group messaging in January 2017. Among the participants
(N = 15), 14 worked in Southern California while 1 worked in North Carolina. Thirteen different
healthcare institutions were identified (10 acute-care hospitals, 1 rehab facility, 1 surgical center,
and 1 K-12 school). Eleven participants, each from a different institution (10 were in southern
California and 1 was in North Carolina), said that they were required to double-check all insulin
doses prior to administration. One participant, the school nurse, reported lack of such a
requirement due to the lack of another nurse in that environment. Three participants, all from the
same larger organization mentioned previously, reported that IDC was not required prior to
subcutaneous insulin administration. All but 1 of 15 participants worked with adult patients.

INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN

12

From these findings, the PI concluded that the traditional nursing practice of conducting an IDC
prior to subcutaneous insulin administration in adults may still be widespread among Southern
California acute care hospitals.
Healthcare Organizational Policy Example
In an effort to investigate why a well-known larger organization of acute care hospitals
does not require IDC prior to subcutaneous insulin administration in adults, the PI sought to
locate this institution’s policy on the public Web and found a policy that covers its institutions in
the Southern California region. This policy states that its purpose is to standardize medication
safety practices and to serve as the minimum standard for its Regional High-Alert Medications
(HAM), which it claims is based on “facility data, literature, and regulatory agency standards”
(Kaiser Foundation Hospital/Southern California Permanente Medical Group [KFH/SCPMG],
2006).
Interestingly, this policy identified only select forms of insulin as HAMs and requires that
an independent double-check be performed prior to the administration of (a) all U-500 insulin
subcutaneous doses, (b) all continuous IV insulin infusions, and (c) all routes of insulin in
pediatric and neonatal patients. At the time this policy was reviewed in January 2017, the policy
did not identify subcutaneous U-100 (standard concentration) insulin as one of the insulin forms
that need IDC prior to administration in adults. Unfortunately, the policy did not cite the
literature on which it based its selection of HAMs. This prompted a review of the current
literature on this topic.
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The Great Debate: Double vs. Single Checking
In order to form a knowledge base of the current evidence that addresses the question,
“What is the effectiveness of independent double-checking (IDC) in reducing subcutaneous
insulin-related medication errors?” the references in the ISMP publication (2013) were
examined. This publication clarified ISMP’s position that IDC should be used selectively
instead of prior to administration of all HAMs due to the time pressure theme identified in the
literature and suggested to have played a role in failed double-checks. The source that The Joint
Commission (TJC) referenced in its 1999 publication, which was the earliest source found to
have advocated for the use of IDC in reducing errors involving insulin, was also reviewed.
A literature search of three electronic databases: Cumulative Index of Nursing and Allied
Health Literature (CINAHL) (1983 to 2012), Nursing & Allied Health (1992 to 2016), and
PubMed (1966 to 2016) was also conducted. For this search the keyword ‘double check’ was
used in combination with (Boolean operator AND) the terms ‘insulin’ or (Boolean operator OR)
‘medication errors’ or (Boolean operator OR) ‘high alert.’ The keyword ‘double check’ was
selected because it is the term used consistently in the PI’s hospital and other hospital policies.
This term was also consistently used in the early ISMP and TJC newsletters that were previously
mentioned to suggest the use of IDC as a medication error reduction strategy (ISMP, 2003; The
Joint Commission, 1999). When this initial search did not yield enough abstracts specific to the
research topic, the keyword ‘double checking’ was used in combination with (Boolean operator
AND) the term ‘insulin.’ This latter search strategy in PubMed yielded the study by Modic et al.
(2016), which is currently the most specific and most recent study that addresses the research
topic. The Modic et al. (2016) study is discussed in the next section. The following are the
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studies deemed noteworthy for their early works, specificity regarding the research topic, and
insight into the attitudes of clinicians from a double-checking to a single-checking environment.
Early landmark study. When The Joint Commission (TJC) advocated for the use of
IDC in an effort to reduce errors involving insulin (1999), it cited a study by ISMP’s Cohen et al.
(1998), which surveyed the nation’s hospitals of which systems-oriented factors allowed for their
highest level of medication safety. The 156 medical-surgical hospitals from 37 states that
participated provided a total of 951 serious medication error incidents. Serious medication errors
were categorized as follows: (a) level 4 errors were errors that resulted in needed intervention to
prevent permanent damage to the patient; (b) level 5 errors were errors that resulted in permanent
patient harm; and (c) level 6 errors were errors that resulted in patient death (Cohen et al., 1998).
Cohen et al. (1998) found that over one-third of all medication errors the hospitals reported
involved the following six categories: allergies, heparin, opiates, patient-controlled analgesia
(PCA) devices, potassium concentrates, and insulin.
Insulin errors accounted for 11% (n = 105) of all error reports, one of which involved a
level 6 error. All remaining 104 incidents involved level 4 errors, among which certain themes
were identified: (a) the inappropriate use of “U” as abbreviation for units; (b) mix up with
heparin 100-unit vials; (c) wrong rate or amount resulting in 10 to 100-fold overdoses; (d) wrong
insulin type used (regular instead of NPH); (e) wrong patient; and (f) duplicative dosing.
Though this landmark study identified these themes related to insulin medication errors, it did
not specify whether subcutaneous routes of insulin were involved in errors, making the findings
less generalizable to patient populations receiving subcutaneous insulin.
Another limitation to the Cohen et al. study (1998) is that the survey period was from
1994 to 1995 when barcode scanning technology was provided by only 0.6% of the surveyed
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hospitals as a measure in place to prevent administration errors, such as heparin mix-ups, wrong
insulin type, and wrong patient errors—error categories reported in this study. Furthermore, in a
more technologically advanced environment where all subcutaneous insulin orders are
electronically entered through a computerized provider order entry (CPOE) system (instead of
free-texted), it is theoretically impossible for prescribers to inappropriately use “U” as
abbreviation for units and for nurses to misinterpret the “U” as “0.” These limitations further
make the study’s findings of the incidence of insulin-related medication errors less generalizable
to modern hospital environments where barcode scanning and CPOE technology are in place to
prevent 4 of the 6 administration errors cited in the findings. Therefore, in view of the presentday use of scanning procedures with medication administration, the need for further research
providing current evidence on this topic is essential to optimal nursing practice.
Most relevant and recent quantitative study. In this most recent study, Modic et al.
(2016) conducted a quasi-experimental study to determine the effectiveness of double-checking
in reducing medication errors at a single-checking hospital. The authors found that out of 5,238
subcutaneous insulin administration opportunities, 1,763 were involved in errors (wrong-time,
wrong-dose, wrong-preparation, omission errors). Of these, only 1.13% (n = 20) were involved
in wrong-dose errors. In contrast, 92.5% (n = 1,630) involved wrong-time errors.
The authors defined a wrong-time error as “an insulin administration deviation greater
than 30 minutes after blood glucose point-of-care testing, as the device downloaded results
immediately to the electronic medical record” (p. 156). This definition is consistent with the
ISMP’s declaration that rapid-acting insulins, such as insulin aspart (NovoLog®), are a timecritical scheduled medication (ISMP, 2011). Time-critical scheduled medications are those
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where early or delayed administration of greater than 30 minutes before or after the scheduled
time may result in harm or significant sub-therapeutic or pharmacological effect (ISMP, 2011).
Though the authors speculated that the reason for the dominance of wrong-time errors
could be due to several non-nurse-contingent factors, such as unavailability of the medication
and ambiguous prescription orders that require communication with the prescriber, they did not
suspect that the additional IDC intervention contributed to the time delay. Their reasoning was
due to the excessive amount of wrong-time errors in both the IDC-performing intervention group
(27.6%, n = 551), and the single-checking control group (33.3%, n = 1,079). However, after
controlling for the single nurse giving insulin, the double-checking intervention was found to
have been effective in decreasing omission errors only, but not any other errors.
Interestingly, the authors stated that the average time that it took to complete an IDC was
five minutes, which could theoretically be a contributing factor to patients not receiving their
dose within the prescribed 30 minutes. This poses the question of whether there is a significant
relationship between the presence or absence of IDC and wrong-time errors.
The authors concluded that although double-checking insulin was originally theorized
and proposed as a strategy to reduce wrong-dose and wrong-preparation errors (The Joint
Commission, 1999), the intervention failed to reduce these types of errors at their acute care
hospital. Modic et al. (2016) called for future studies to investigate how to reduce wrong-time
errors, which they thought were also the most prevalent type of subcutaneous insulin-related
medication error in other hospital settings.
Systematic review. To determine the evidence on the effectiveness of IDC in decreasing
medication error rates, Alsulami, Conroy, and Choonara (2012) conducted a systematic review
of 6 electronic databases—Embase, Medline, British Nursing Index and Archive, CINAHL,
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National electronic Library for Medicines (NeLM) and PsycINFO—for articles describing IDC
use for dose calculation, dispensing, and administration in adults and children up to October,
2010. Although the search yielded 752 abstracts, all but 106 were unrelated to double-checking
in the medication process. After the full text of each of the 106 articles was reviewed, 92 were
further excluded due to being unrelated to double-checking medications. After manual review of
the 14 articles’ references, two more studies were added, totaling 16 articles. The 16 articles
included (a) 3 quantitative studies, (b) 2 mixed-methods studies, (c) 9 qualitative studies, and (d)
2 previously conducted systematic reviews. Two of these are relevant to this project.
Quantitative study. One of the three quantitative studies was a randomized controlled
clinical trial conducted over a 46-week study period. This study, which detected 319 errors
among 129,234 medications in a geriatric unit, showed a statistically significant reduction in the
medication error rate from 2.98 to 2.12 per 1000 medications when two nurses administered the
medications compared to a single nurse (Kruse, Johnson, O'Connell, & Clarke, 1992). Through a
time and motion study, Kruse et al. (1992) indicated that this reduction in errors came at a cost of
an additional 17.1 hours of nursing time required per 1000 medications administered. The
authors concluded that the high cost on nursing workload would make the intervention timeconsuming, impractical, and thus, un-endorsable.
Mixed-method study. Jarman, Jacobs, and Zielinski (2002) conducted a
descriptive/observational study evaluating the effect of a policy change that was introduced in an
Australian hospital whereby single-checking replaced the historically performed doublechecking of a list of medications, including “insulin according to sliding scale,” over a period of
seven months. The quantitative part of the study had two data collection sources. One involved
tracking incident reports, which showed there were only five related error incident reports filed
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during the double-checking period compared to four error incident reports filed during the
single-checking period. Although this source had its limitation due to a small sample and its
method of tracking errors through nurse-initiated incident reports, the other quantitative data
source contributed to the evidence related to the impact of single-checking on nurses.
After the seven-month study, a 15-item questionnaire asked nurses (N = 129) about the
following: (a) level of satisfaction with single-checking, (b) perceived level of responsibility and
confidence with single-checking, and (c) the extent to which the change to single-checking had
decreased the amount of time taken for the administration of medications. The nurses reported
(a) high levels of satisfaction with the change, (b) high levels of responsibility and confidence as
a result of the change, and (c) that the change had a high impact on the amount of time taken to
give medications, with the perceived average amount of time saved being 20 minutes.
The questionnaire’s open-ended questions yielded qualitative data that revealed recurring
themes. With regards to the high levels of responsibility, the nurses reported heightened selfaccountability through statements of “I read the order more carefully,” “I am extremely thorough
and take more time, knowing I am not holding up someone else,” and “I double-check
everything with myself before administering the drug.”
With regards to the nurses’ perception of the effectiveness of single-checking in saving
time, nurses reported that time-savings came from not having to find a second nurse (particularly
important to night shift nurses) and interrupt colleagues or be interrupted by them. The nurses
reported that the time saved from not having to double-check medications enabled them to
administer medications in a timely manner and provided them additional time to be with their
patients, increasing their level of satisfaction and autonomy.
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Continuation of the Frameworks
As previously mentioned, this project was based on the Iowa Model to guide its progress
and on the human error theory to explain the risks of the overuse of independent double-check
processes in preventing errors related to high-frequency tasks, such as subcutaneous insulin
administration. The Iowa Model of Evidence-Based Practice to Promote Quality of Care (Titler
et al., 2001; see Appendix A) is used to guide the direction for evidence-based practice (EBP)
development in a clinical setting, such as a hospital. Since there is not sufficient evidence to
support or refute the effectiveness of the use of IDC in reducing subcutaneous insulin-medication
errors, the Iowa Model suggests moving forward either (a) by basing practice on other types of
evidence (such as case reports, expert opinion, scientific principles, theory) or (b) by conducting
research.
Expert opinion as evidence. The expert opinion of the Institute for Safe Medication
Practices (ISMP) states the following:
ISMP has never explicitly encouraged the regular use of IDC’s for subcutaneous insulin
(other than U-500). For intravenous (IV) insulin, ISMP does support an independent
double-check (IDC). The ISMP High-Alert Medications list notes that “manual
independent double-checks are not always the optimal error-reduction strategy and may
not be practical for all of the medications on the list.” The overuse of the independent
double-check for the high volume of subcutaneous insulin doses is detrimental [emphasis
added] to the effective use of this mid-level process with other more important high-alert
medications. (G. Banasser, personal communication, January 16, 2017)
The ISMP is nationally recognized by medication safety teams and by The Joint Commission as
an authority and advocate for safe medication practices.
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Error theory as evidence. Additionally, the Iowa Model allows theory to be a type of
evidence (Titler et al., 2001). There are several theories behind what is thought to cause errors
and how to properly address them. While Chapter 1 mainly explored the more encompassing
human error theory by Reason (2000), Chapter 2 explores this theory’s relationship to highreliability theory (HRT) and normal accident theory (NAT).
To review, the system approach to human error theorizes that to err is naturally human
and that attempts must be focused on maximizing system barriers in order to minimize errorprovoking conditions in the workplace. This system approach is in contrast to the person
approach that is more focused on error-reduction among the front-line defense that consists of
fallible humans. Since double-checking requires that one imperfect person check the work of
another flawed human, it is not always the optimal system approach to reducing medication error
(ISMP, 2003; ISMP, 2007; ISMP 2012; ISMP 2014). Due to the tendency of people to see what
they expect to see, the effectiveness of double-checking is diminished (ISMP, 2003; Reason,
1990).
The system approach is consistent with the assumption that “though we cannot change
the human condition, we can change the conditions under which humans work” (Reason, 2000,
p. 768). In an effort to improve the system (reduce medication errors) under which bedside
nurses work, the time pressure that comes with an independent double-check must be relieved
since it was previously theorized and found to have had some contribution to the nurse workload
associated with a high-frequency task such as subcutaneous insulin administration (Jarman et al.,
2002). Furthermore, the high-reliability theory (HRT) and normal accident theory (NAT)
provide unique perspectives on the limitations of independent double-checks in reducing system
errors.
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High-reliability theory. U.S. Navy nuclear aircraft carriers, nuclear power plants, and air
traffic control centers are three types of high-reliability organizations (HRO) that have been
identified to be “systems operating in hazardous conditions that have fewer than their fair share
of adverse events” (Reason, 2000). High-reliability theory’s main concern is to assure the
reliability of procedures in high-hazard settings (Tamuz & Harrison, 2006), making it applicable
to hospital procedures. One of the ways that reliability is enhanced is through redundancy,
provided that it is selective. The ISMP said the following warning against the non-selective use
of IDC:
With workload issues looming heavily over practitioners, independent double checks
should only be used for very selective high-risk tasks or high-alert medications (not all)
that most warrant their use. Selected tasks and medications should not be based simply
on those which have historically always been double checked, but on a careful
assessment of scenarios with the greatest risk. As such, ISMP does not recommend use
of an independent check for all high-alert medications or all high-risk tasks… Fewer
double checks strategically placed at the most vulnerable points of the medication use
process will be much more effective than an overabundance of double checks. (ISMP,
2013)
High-reliability theory proposes a selective use of redundancy processes, like IDC, because an
overreliance on double-checking is thought to actually reduce one’s mindfulness of the safety
risks involved, possibly inducing front-line workers (such as nurses) to consider the requirement
common and superficially routine.
Normal accident theory. Normal accident theory (NAT) attempts to “raise awareness of
unavoidable risk of major system failures in industries using tightly coupled, interactively
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complex technologies” such as nuclear power plants, where there is low tolerance for system
failures combined with a considerable risk for accidents (Tamuz & Harrison, 2006). This
framework also helps demonstrate the limits of redundancy by highlighting that redundancies
can contribute to accidents when they lack independence, increase complexity, and diffuse
personal responsibility (Sagan, 2004). This is consistent with the findings of the following
qualitative study.
Armitage (2008) investigated the themes involved in medication errors that occurred
while double-checking was in place at a large teaching hospital in the U.K by interviewing a
sample (N = 40) of 15 doctors, 15 nurses, 7 pharmacists and 3 pharmacy technicians who had
experience with drug errors. As a result of the study, the following 4 categories of criticisms
regarding IDC were identified: (a) deference to authority (n = 9), in which junior members
reported deferring to the calculation of more senior colleagues without independently checking
their calculation; (b) reduction of responsibility (n = 10), in which the clinician reported being
complacent due to a false sense of diffused responsibility, thinking that another clinician will
detect his/her mistake; (c) automatic processing (n = 9), in which the clinician reported not
performing the calculation independently due to being in mindless “autopilot” mode and in
contrast to proper IDC where second checker is separated by time and distance; and (d) lack of
time (n = 10), in which the clinician reported being time-poor, lowering his/her quality of
adherence to proper IDC.
A limitation of this study is that not all participants were critical of the process, which
accounted for only 38 tabulated responses, where some participants provided more than one
criticism. It is interesting to note that the participants without criticisms against IDC primarily
held more senior, management level positions.
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Additionally, double-checking procedures may delay the identification and correction of
errors (Reason, 1997). For example, if during a double-check, a mistake is detected and
corrected by hospital pharmacy staff before it reaches the patient, the mistake may not be
classified and reported as an error. Such misinterpretation may delay or altogether miss the
opportunity for a root cause analysis to occur and prevent similar errors from happening again
(Tamuz & Thomas, & Franchois, 2004).
Summary
This chapter discussed a survey of nurses’ current practice surrounding double-checking
subcutaneous insulin and further examined error theories and literature, supporting the need to
investigate this topic. Hospital policymakers need to be aware of the limitations documented in
the literature related to independent double-checking. In an effort to progress the institution
toward a safe, high-reliability organization (HRO), organizations must recognize that though
“human variability is a force to harness in averting errors” leaders must also “work hard to focus
that variability and…constantly [be] preoccupied with the possibility of failure” (Reason, 2000).
HROs need to consider accomplishing this through a systems approach where those at the bluntend of errors (i.e., those in managerial or policy-making positions) modify the conditions under
which those at the sharp-end work (i.e., frontline workers). A hospital organization that seeks to
be an HRO must recognize that to err is naturally human and that with a systems approach,
minimizing the factors that could provoke errors would be a better approach than relying on
techniques that are contingent on its fallible front-line workers.
The next chapter presents the design and methodology of the project that was conducted
to investigate if there would be a difference in medication errors surrounding nurses’
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Chapter 3
Methodology
This quantitative quasi-experimental project was composed of a two-phase pilot study
that replicated parts of the design and methods used in the study by Modic et al. (2016). This
study investigated if there would be a difference in medication errors related to subcutaneous
insulin while single-checking was in place compared to when independent double-checking
(IDC) was in place. Additionally, this pilot study aimed to investigate if there was a relationship
between select variables and the occurrence of a medication error involving subcutaneous
insulin. This chapter details the design and methods used to develop and implement the twophase pilot study.
Target Population and Setting
The project was approved by the hospital’s Institutional Review Boards (IRB) through
expedited review (see Appendix B) as a two-phase pilot study at a 27-private-bed progressive
care unit in a southern California acute care hospital. This sub-intensive care unit (Sub-ICU)
serves an adult population with lower acuity than that of a standard intensive care unit (ICU).
However, the patients require a higher level of care than those generally found on a telemetry or
medical-surgical unit. Its registered nurses (RNs) are trained to care for those who need
continuous telemetry monitoring, mechanical ventilation (tracheostomies and bilevel positive
airway pressure [BiPAP]) and select un-titratable vasopressors at preset limited doses.
Maximum nurse to patient ratio is 1:3. Sub-ICU RNs routinely administer rapid-acting and longacting subcutaneous insulin doses with the use of patient-exclusive multi-dose insulin pens
(NovoLog® FlexPen® and Lantus® SoloSTAR®, respectively) with the standard concentration
of 100 units/mL (U-100). Before this project, RNs were required to perform double-checking
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prior to administration of a U-100 subcutaneous insulin dose; however, they were not required to
do so prior to withholding a dose. Computer workstations on wheels (WOWs) are used to access
patients’ electronic health records (EHR), including the electronic medication administration
record (eMAR). The EHR system at the time of the pilot study was called Allscripts Sunrise
Clinical Manager ™ (SCM).
Inclusion and exclusion criteria. Adult patients (at least 18 years of age) who were
admitted to the Sub-ICU from November 10, 2017 at 0700 through January 1, 2018 at 0659 were
included into the convenience sample, provided that they had subcutaneous insulin ordered in U100 concentration (100 units/mL); the PI set audit filters in the EHR to track these patients into a
patient list. For assessment of wrong-time errors, only those on blood glucose monitoring
(Accu-chek®) every 4 hours (scheduled at 0800, 1200, 1600, 2000, 0000, and 0400) and those
for whom long-acting insulin was ordered outside of mealtimes (i.e., scheduled at bedtime) were
included. Mealtime-related insulin doses were excluded from wrong-time error assessment due
to the complexity in controlling for their timeliness given varying length of times that patients
take to complete meals. To review, the definition of a wrong-time error in this study is
consistent with that of Modic et al. (2016) as “an insulin administration deviation greater than 30
minutes after blood glucose point-of-care testing, as the device downloaded results immediately
to the electronic medical record” (p. 156). The facility used in this study allowed for the results
of blood glucose point-of-care testing to be downloaded immediately to the EHR along with a
time stamp.
Subcutaneous insulin documentation by full-time, part-time, and per diem RNs that were
regular Sub-ICU staff who had gone through or were going through orientation in Sub-ICU were
included in data collection during both phases, provided that the RN (1) had successfully
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returned demonstration with the principal investigator (PI) on how to calculate the subcutaneous
insulin dose and (2) had acknowledged electronic receipt and understanding of the pilot manual.
By the start of this project, 47 Sub-ICU RNs were eligible to participate. In the middle of the
project, four Sub-ICU RNs returned from their leaves of absence and two more RNs were newly
hired to Sub-ICU. Therefore, by the end of this project, a total of 53 Sub-ICU RNs were eligible
to participate. During the single-checking phase, subcutaneous insulin documentation by visiting
(“floating”) RNs and nursing students were excluded from the sample selection.
Project Procedures
Phase 0: Pre-pilot briefing sessions. Before the actual pilot study was implemented, the
PI met numerous times with Sub-ICU RNs individually and in small group in-service sessions to
brief them face-to-face about the aim of the pilot study and its scope in the Sub-ICU. Each
session lasted 10-15 minutes, with the number of participant RNs fluctuating each session
depending on RN availability on a given shift. The main objective of these sessions was for the
Sub-ICU RN to demonstrate the correct method in calculating the appropriate insulin dose for an
example situation, using the hospital’s sliding scale and algorithm ratios, especially because
there had been certain situations where the PI noticed inconsistent calculation methods among
RNs which sometimes yielded different doses (e.g., when patient parameters fall outside the
sliding scales). The PI printed copies of the hospital’s sliding scale and algorithm ratios and
distributed these to the Sub-ICU RNs in each session. The PI then asked the Sub-ICU RNs how
much subcutaneous insulin they would give a patient in three different scenarios (see Appendix
C). At the end of the session, the PI showed the Sub-ICU RNs a sample of the “Errors
Prevented” form (see Appendix D, Figure D1) and answered participant questions. A four-page
pilot manual was also emailed to these RNs as a reference for the workflow changes during the
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two phases of the pilot study (see Appendix D). At the start of the pilot study, a hardcopy of the
manual was also printed in heavy cardstock and placed in the unit’s medication preparation room
for easy access.
Phase 1: Double-checking phase. The first phase, which was double-checking,
functioned as a control since double-checking was the hospital standard prior to this project.
This phase lasted 3 weeks, from November 10, 2017 at 0700 until December 1, 2017 at 0659.
Per hospital policy and approved pilot protocol, the double-checking process and subcutaneous
insulin administration (if indicated) consisted of the following steps:
1. After the primary RN checked the patient’s blood sugar and/or grams of carbohydrates
eaten, he/she (a) calculated the appropriate insulin dose per the ordered algorithm ratio in
the eMAR; (b) prepared the insulin pen if a dose was indicated; and (c) verified that the
insulin pen had the appropriate patient label and expiration date.
2. The primary RN sought a second RN to participate in an IDC, regardless if insulin
administration was deemed unnecessary.
3. The second RN verified the blood glucose result that was charted in the EHR or
shown in the blood glucose meter (Accu-chek®), obtained for that insulin administration
period. If insulin was also ordered for carbohydrate coverage, the second RN verbally
verified with the primary RN the grams of carbohydrates the patient ate.
4. If the patient met criterion/a for administration of an insulin dose, the second RN
reviewed the eMAR for which of the four insulin dosing algorithms was ordered and
calculated the dose indicated. The second RN inspected the dose that the primary RN
dialed on the insulin pen and confirmed it was the correct insulin pen (e.g., correct patient
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label, current expiration date). The primary RN opened the insulin eMAR task and
entered the second RN’s name in the mandatory co-signature field.
5. If the patient did not meet criterion/a for administration of an insulin dose, the second
RN verified that the dose should be held. On the eMAR task, the primary RN entered
“0” units to be given and entered the second RN’s name in the mandatory co-signature
field. The primary RN did not administer a dose.
6. Afterwards, the pair filled out one preprinted “Errors Prevented” form (see Appendix
D, Figure D1), whether the pair decided to administer or omit a dose. They inserted the
form into a designated, locked drop box (see Appendix D, Figure D2) located in the SubICU medication room. The preprinted forms were stocked in close proximity to the drop
box, which was in bright red color for easy visibility.
7. If a dose was indicated and confirmed by the second RN, the primary RN brought a
WOW into the patient’s room and opened the eMAR. The hospital’s barcode scanning
process for medication administration was followed: The primary RN scanned the
patient’s armband and the insulin pen barcode before administering the dose
subcutaneously.
Phase 2: Single-checking phase. During the second phase, which was the intervention
phase, the Sub-ICU RN was temporarily allowed to administer subcutaneous insulin (U-100) to
Sub-ICU patients without performing an IDC with a second RN. This phase lasted 4 weeks,
from December 1, 2017 at 0700 until January 1, 2018 at 0659. Per IRB-approved pilot protocol,
the single-checking process consisted of the following steps:
1. The primary RN checked the patient’s blood sugar and/or grams of carbohydrates
eaten.
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2. If the patient met criterion/a for administration of an insulin dose, the primary RN (a)
calculated the appropriate insulin dose per the ordered algorithm ratio in the eMAR, (b)
prepared the insulin pen, and (c) verified that the insulin pen had the appropriate patient
label and expiration date. The primary RN entered the name of the principal investigator
(PI) in the eMAR insulin task’s mandatory co-signature field as a work-around since the
hospital’s information technology (IT) department could not selectively turn off this
mandatory field for one department only. In other words, the PI became the primary
RN’s imaginary double-checker for the purpose of completing the eMAR insulin task
documentation. This step “pushed” notifications to the PI’s Signature Manager Inbox.
3. If the patient did not meet criterion/a for administration of an insulin dose, on the
eMAR task, the primary RN entered “0” units to be given and entered the PI’s name in
the mandatory co-signature field for the same reason as stated in step 2. The primary RN
did not administer a dose.
4. If a dose was indicated, the primary RN brought a WOW into the patient’s room and
opened the eMAR. The hospital’s barcode scanning process for medication
administration was followed: The primary RN scanned the patient’s armband and the
insulin pen barcode before administering the dose subcutaneously.
5. Because the PI used eMAR task audits as the main error assessment tool during the
single-checking phase, the RN did not use the “Errors Prevented” form (see Appendix D,
Figure D1) that was used during the double-checking phase. However, because there was
no other method to audit wrong-preparation errors (e.g. wrong insulin pen used for
patient) from performing eMAR task audits, the Sub-ICU RN was instructed to selfreport such an event. If the RN made a wrong-preparation error that he/she contributed to
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the lack of a double-checking requirement, he/she was instructed to self-report through
filling out an anonymous “Self-Report of Wrong-Preparation Error” form (see Appendix
D, Figure D3) and filing an online internal risk management report called “MIDAS.”
Preprinted self-report forms were stocked in close proximity to the red drop box in the
medication room. The RN was instructed to insert this form into the locked red drop box.
Instrumentation
Phase 1: Double-checking phase. Modic et al. (2016) provided preprinted cards for
nurses to use as a means of reporting the type of insulin errors prevented by an IDC. Similarly,
this project’s PI designed this project’s “Errors Prevented” form, though with less words and
with bolded text of key words for easy visualization (see Appendix D, Figure D1). These forms
were preprinted and made accessible to Sub-ICU RNs in the Sub-ICU medication room. Each
pair of Sub-ICU nurses was instructed to fill out one card anonymously for every IDC they
performed prior to administration or omission of a subcutaneous insulin dose. These forms were
stocked next to the red drop box (see Appendix D, Figure D2). Day shift RNs (shift hours from
0700-1930) were instructed to use the forms printed in pink cardstock while night shift RNs
(1900-0730) were instructed to use forms printed in blue cardstock. The color of form used
during the 30-minute shift change overlap period depended on which shift the primary RN
worked.
Phase 2: Single-checking phase. As previously mentioned, if the RN made a wrongpreparation error that he/she contributed to the lack of a double-checking requirement, he/she
was instructed to self-report through filling out an anonymous “Self-Report of Wrong
Preparation Error” form (see Appendix D, Figure D3) and filing an online internal risk
management report (“MIDAS”).
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Data Collection and Analysis
Collection. Demographic data collected (through EHR chart review) from patients
whose medication administration were recorded in the study were age, gender, diabetes type, and
isolation precaution type. Although no direct nurse demographics were collected, the shift type
(day or night) of the administering RN was collected. Outcome measures and their data
source(s) are listed in Table 1. The hospital’s internal risk management software (“MIDAS”)
was also used as an additional data source for all outcome types although it must be noted that
these types of reports are clinician-initiated and are seldom filed, possibly due to the long filing
process involved. For example, between July 2016 and December 2016, only 5 insulin-related
errors were filed. This is why eMAR task audits and the preprinted forms were used as the main
data sources to track outcome measures.
Table 1
Data Collection Sources Based on Outcome Measures
Outcome type:

Data source during DOUBLEchecking

Data source during
SINGLE-checking

Wrong-time (only for doses
scheduled every 4 hours and
non-mealtime Lantus doses)
Wrong-dose (over-dosing and
under-dosing)
Inappropriate omission

eMAR audits

eMAR audits

eMAR audits

eMAR audits

eMAR audits

eMAR audits

Wrong-preparation

“Errors Prevented” form

No insulin errors prevented

eMAR audits

“Self-Report of Wrong
Preparation Error” form
eMAR audits

Note. The hospital’s internal risk management software (“MIDAS”) was used as an additional
data source for all outcome types. eMAR = electronic medication administration record.
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Analysis. The Statistical Package for the Social Sciences (SPSS, version 24) software
was used to analyze the data. Descriptive statistics were used to analyze means, standard
deviations, frequencies, and percentages of demographic variables and outcome measures.
Inferential statistics were conducted using: (a) an independent samples t-test to determine
differences between the control group (double-checking phase) and the experimental group
(single-checking phase); and (b) chi-square test of independence to determine the difference
between frequencies of the nominal variables between the two groups. Significant differences
between the control and experimental groups were determined by a p value set at £ .05. Single
and multiple categorical logistic regression tests were used to control for demographic variables.
A Pearson r correlation test was performed to determine if there was a relationship between
select variables and medication error likelihood. Furthermore, an analysis of variance (ANOVA)
and subsequent post-hoc tests were conducted to determine which of the isolation precaution
types had a significant effect on the time lapse (in minutes) between the blood glucose check and
the administration of the insulin dose.
Human Subjects Protection
In order to comply with the hospital’s and Vanguard University’s regulations regarding
human subjects protection, the principal investigator (PI) obtained training (see Appendix E)
from the Collaborative Institutional Training Initiative (CITI) online program and training
modules from the National Institutes of Health (NIH). Nurses’ and patients’ confidentiality
were observed according to the Health Insurance Portability and Accountability Act (HIPAA)
regulations as follows:
General principles. Only the PI had access to identifiable data. The thesis advisor and
the university’s statistician were given access to non-identifiable data in order to assist with data
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analysis; the hospital’s Clinical Research Office (CRO) and Nurse Research Council (NRC) were
also given access to the non-identifiable data in order to comply with the hospital’s pilot study
data report-back guidelines.
Data handling procedures. Patients’ confidentiality was observed according to the
HIPAA regulations in that the collective (rather than individual) demographic data of the sample
(with no patient identifiers) were stored in the PI’s password-protected Macbook laptop. These
files, which had no patient identifiers, only contained age, gender, diabetes type, and isolation
type demographic data. On the other hand, data with identifying patient information were stored
in the form of a password-protected electronic file that was saved in the PI’s hospital IT-generated
and secured computer directory. Hospital IT confirmed that this directory and the files contained
within it were, are, and will only be accessible to the PI through her unique network credential
username and password, which were not shared with anyone.
During eMAR task audits, it was inevitable for the PI to see the identifying information of
the patients who were given subcutaneous insulin and of the nurses who were involved in
subcutaneous insulin medication administration. During these eMAR audits, patients’ visit
account numbers (VANs) were collected while identifiable nurse data were not collected.
During these eMAR audits, the investigator maintained a Microsoft Excel worksheet, identified
here as “Worksheet 1” (see Appendix D, Figure D4). The password required to open Worksheet
1 was only known to the PI and consisted of at least 12 characters with lowercase letters,
uppercase letters, numbers, and a special character. Summarized tallies of the data from
Worksheet 1 (e.g., the number of wrong dose incidents on a given date) without patient
identifiers were stored in the form of other Microsoft Excel worksheets, saved in the
investigator’s password-protected Macbook computer. In summary, electronic files with patient

INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN

35

identifiers did not leave the hospital’s secured computer network system. Only files with nonidentifiable data were stored in the investigator’s password-protected Macbook laptop.
Data destruction procedures.
Destruction of identifiable data. Files with identifiable data (i.e., Worksheet 1) will be
destroyed no earlier than December 2019. This will allow time for any record review at the
hospital, should the data’s validity be questioned. The electronic file will then be disposed of by
electronically deleting the file from the hospital-secured computer and subsequently emptying its
“Recycle Bin.”
Destruction of non-identifiable data. Since the PI intends to publish findings or
disseminate non-identifiable data results outside of the University, it may be necessary to keep
the non-identifiable data for an undetermined length of time.
Summary
This chapter described the design and methodology of the thesis project that was
conducted to investigate: (1) if there would be a difference in medication errors related to
subcutaneous insulin while single-checking was in place compared to when double-checking was
in place and (2) if there would be a relationship between select variables and the occurrence of a
medication error involving subcutaneous insulin. Inclusion and exclusion criteria used in
accessing the convenience sample were identified as well as the step-by-step procedures
implemented during the two-phase pilot study. Tools used to compare the data before and during
the intervention, and statistical analyses were also discussed. Furthermore, this chapter
explained how data files were and will be stored and destroyed in a confidential manner, in
keeping with human subjects protection. The next chapter will present the study’s results.
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Chapter 4
Results
This quantitative quasi-experimental pilot study aimed to answer two questions: (1) Is
there a significant difference in medication errors related to subcutaneous insulin while singlechecking is in place compared to when independent double-checking (IDC) is in place; and (2) Is
there a relationship between select variables and the occurrence of a medication error involving
subcutaneous insulin? This chapter details the analysis performed on the data collected and the
results that answer the questions of this two-phase pilot study.
Data Levels of Measurement
The collected data were numerically coded in Microsoft Excel and imported into the
Statistical Package for the Social Sciences (SPSS, version 24) software for data analysis. Table
2 lists each variable’s level of measurement.
Table 2
Data Variables and Their Selected Levels of Measurement
Variable

Nominal

Ratio (“Scale” in
SPSS)

checking type
X
age (in years)
X
gender
X
DM type
X
isolation type
X
shift type
X
time lapse (in minutes)
X
wrong-time
X
over-dosed
X
under-dosed
X
inappropriate omission
X
wrong BG charted
X
wrong preparation
X
Note. SPSS = Statistical Package for the Social Sciences; DM = diabetes mellitus; BG = blood
glucose.
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Data Analysis
As mentioned in Chapter 3, descriptive statistics using means, standard deviations,
frequencies, and percentages were used to analyze demographic variables and outcome
measures. Inferential statistics were conducted using: (a) independent samples t-test to compare
the means between the control group (double-checking phase) and the intervention group (singlechecking phase) and (b) chi-square test of independence to determine the difference between
frequencies of the nominal variables between the two groups. Significant differences between
the control and intervention groups were determined by a p value set at £ .05, with all tests 2sided. A Pearson r correlation test was also performed to determine if there is a relationship
between sample variables and likelihood of medication error occurrence. Furthermore, an
analysis of variance (ANOVA) and a post-hoc test were conducted to determine which of the
isolation precaution types had a significant effect on the time lapse (in minutes) between the
blood glucose check and the administration of the insulin dose. Single and multiple categorical
logistic regression tests were also performed to control for demographic variables.
The Findings and Interpretation
Demographics of double-checking and single-checking groups. Over a seven-week
period, there were a total of 1,528 opportunities (collected through eMAR chart audits) for
subcutaneous insulin administration and omission among the 92 patients that were included in
the sample. Patient mean age was 72.15 (±15.1) years and 56.5% (n = 52) were male. Table 3
provides a comparison of the 92 patients’ characteristics between the double-checking (n = 37)
and the single-checking (n = 55) groups although it does not include the isolation type
demographic variable because the PI noticed that depending on the date and time, a patient could
have different isolation status (i.e., placed in enteric isolation after stool tested positive for C.
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difficile). Table 3 shows that there was no significant difference in the age, gender, or diabetes
type between the two groups (p > .05).
Table 3
Characteristics of the Sample Patients
Variable
Age, in years
Gender (n)
Male

Doublechecking
group (n = 37)
M = 72.30
SD = 14.9

Singlechecking
group (n = 55)
M = 72.05
SD = 15.365

t

c2

p
Value

.075

N/A

.94

54.1% (20)

58.2% (32)

N/A

.153

.695

DM type (n)
N/A
--.567a
Type 1
5.4% (2)
0
Type 2
35.1% (13)
41.8% (23)
None
2.7% (1)
1.8% (1)
None, but on steroids
5.4% (2)
1.8% (1)
Pre-diabetes
2.7% (1)
0
Gestational
0
1.8% (1)
Unknown
5.4% (2)
7.3% (4)
Unknown, but on steroids 5.4% (2)
1.8% (1)
Unspecified
32.4% (12)
40% (22)
Unspecified, but on
5.4% (2)
3.6% (2)
steroids
Note. n = sample; N = total sample; M = mean; SD = standard deviation; DM = diabetes
mellitus. Means and SD between continuous variable (age) of the two groups were compared
using independent samples t-test; frequencies of the nominal variables (gender and DM type)
were compared using chi-square test of independence.
a
Using two-sided Fisher’s exact test.
Table 4 provides a comparison of the 1,528 insulin opportunities yielded from the 92 patients.
The isolation type, the shift during which the administering RN worked, and the time lapse from
the blood glucose check to the insulin administration time were analyzed. The double-checking
group had 740 opportunities while the single-checking group had 788. Even though these 1,528
insulin opportunities were yielded from 92 patients, each opportunity was treated as an
independent event for purposes of analyzing data in Tables 4 and 5.
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Table 4
Characteristics of the 1,528 Subcutaneous Insulin Administration and Omission Opportunities
Variable
Age of pt, in years
Gender of pt (n)
Male

Double-checking
group (n = 740)
M = 68.34
SD = 18.43

Single-checking
group (n = 788)
M = 72.57
SD = 13.39

t

c2

5.118a

N/A

61.1% (452)

63.1% (497)

N/A

.642

.423

N/A

---

---b

N/A

104.1

<.001c

N/A

.020

.886

2.931a

N/A

.004a

DM type of pt (n)
Type 1
Type 2
None
None, but on steroids
Pre-diabetes
Gestational
Unknown
Unknown, but on steroids
Unspecified
Unspecified, but on steroids

8.5% (63)
25.9% (192)
0.1% (1)
9.2% (68)
0.8% (6)
0
10.7% (79)
3.4% (25)
33.6% (249)
7.7% (57)

0
41% (323)
3.8% (30)
1.6% (13)
0
0.9% (7)
6.7% (53)
3.2% (25)
40.1% (316)
2.7% (21)

Isolation precaution type of pt (n)
Airborne
Enteric (C. difficile)
Contact
Contact and droplet
Droplet
Not in isolation

0.8% (6)
3.5% (26)
9.5% (70)
0
0.7% (5)
85.5% (633)

0
7% (55)
18.8% (148)
0.1% (1)
7.2% (57)
66.9% (527)

Shift of administering RN (n)
Day
Night

67.3% (498)
32.7% (242)

67.6% (533)
32.4% (255)

Md = 32.54

Me = 20.84

SDd = 43.16

SDe = 29.76

Time lapse from BG check to
insulin administration, in minutes

p Value
a

<.001

Note. n = sample; N = total sample; pt= patient; M = mean; SD = standard deviation; DM = diabetes
mellitus; BG = blood glucose.
a

When equal variances not assumed. bFisher’s exact test cannot be computed. cUsing two-sided Fisher’s

exact test. dOut of 155 administered (not omitted) opportunities. eOut of 225 administered (not omitted)
opportunities.
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Differences in characteristics between the two checking groups. As shown in Table 4,
between the two groups, there was a significant difference in mean age (t1343= 5.118, p < .001)
and in mean time lapse from blood glucose (BG) check to insulin administration (t253= 2.931, p
= .004), even when equal variances are not assumed. The single-checking group was older than
the double-checking group, with the average age for the single-checking group being 72.57
(±13.39), while the average age of the double-checking group was 68.34 (±18.43). The doublechecking group had a longer time lapse from the BG check to insulin administration, with its
average time lapse being 32.54 (±43.16) minutes, while the average time lapse of the singlechecking group was 20.84 (±29.76) minutes. This meant that the double-checking group had a
time lapse that was 11.7 minutes longer than that of the single-checking group. Additionally,
there was a significant difference between the isolation types encountered in the two groups,
with the single-checking group encountering more isolation frequencies than the doublechecking group (c2 [5] = 104.1, p < .001).
Correlations among the variables. Table 5 summarizes the results of the Pearson r
correlation test that was performed to determine if there was a relationship between certain
sample variables and the likelihood of medication error occurrence. The likelihood of error
occurrence was based on predicted probability values (continuous variable) yielded from logistic
regression. There was a significant relationship between age and the likelihood of error
occurring (r = .061, p = .017), although the relationship was weak and could be attributed to
error, since every age--including outliers--was listed instead of grouped in ranges. Additionally,
there was a significant relationship between the shift type and the likelihood of error occurring (r
= -.052, p = .042). On the other hand, there was not a significant relationship between the
checking type and the likelihood of error occurring (r = .002, p = .942). However, because of the
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nominal nature of the shift type and check type variables, the interpretation of these correlations
using a Pearson r correlation may be limited. Therefore, chi-square tests of independence were
performed on these nominal variables. The results will be discussed next.
Table 5
Correlations of Variables with the Likelihood of Error Occurring
Variable

Level

Coding in SPSS

ra

p Valuea

Age
Gender
Shift type
Checking type

Ratio
Nominal
Nominal
Nominal

Age in years
1 for male; 2 for female
1 for day; 2 for night
1 for single; 2 for double

.061
.006
-.052
.002

.017
.811
.042
.942

Note. A total of 1525 opportunities were used to report the Analog of Cook’s influence statistics.
Also note that all the variables listed, except for age, are at a nominal level of measurement,
which could limit the interpretation of these correlations. The likelihood of error occurrence was
based on predicted probability values (continuous variable) yielded from logistic regression.
SPSS= Statistical Package for the Social Sciences.
a
Based on Analog of Cook’s influence statistics.

Differences in outcome measures between the day and night shift groups.
Results from the eMAR task audits, day versus night shift. In order to more closely
look at the difference in error rates between the shift groups and error rates, frequencies were
compared through a chi-square test of independence (Table 6). The day shift group had
significantly more “any one error” than the night shift (c2 [1] = 16.057, p < .001). The day shift
group also had significantly more “wrong-time” errors than the night shift group (c2 [1] =
36.718, p < .001).
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Table 6
Frequencies of the Outcome Measures Between the Day Shift and Night Shift, eMAR Audits
Outcome Measure

Day shift (n)

Night shift (n)

c2

df

p Value

Any one error?
Yes
Total (N)

12.2% (126)
1031

5.6% (28)
497

16.057

1

<.001

Administration error
Wrong time?
Yes
Total (N)

38.7% (79)
204

11.4% (29)
176

36.718

1

<.001

Over-dosed?
Yes
Total (N)

1.4% (9)
633

0.3% (1)
313

---

---

Under-dosed?
Yes
Total (N)

1.7% (11)
635

1% (3)
315

---

---

Wrong BG charted?
Yes
Total (N)

2.5% (26)
1027

1% (5)
494

---

---

Wrong preparation?
Yes
Total (N)

0.5% (3)
644

0
316

---

---

1.6% (6)
387

0.6% (1)
181

---

---

Inappropriate
omission?
Yes
Total (N)

a

.179

a

.408

a

.053

a

.555

a

.440

Note. eMAR: electronic medication administration record; n = sample; N = total sample; BG =
blood glucose.
a
Using two-sided Fisher’s exact test.
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Results from the “Errors Prevented Form” tallies, day versus night shift. The “Errors
Prevented Form” (see Appendix D, Figure D1) was made available to Sub-ICU RNs to selfreport prevented errors during the double-checking phase only. Day shift RNs (shift hours from
0700-1930) were instructed to use the forms printed in pink cardstock while night shift RNs
(1900-0730) were instructed to use forms printed in blue cardstock. The color of form used
during the 30-minute shift change overlap period depended on which shift the primary RN
worked. Table 7 compares outcome measures between the day and night shift. Note that the
“wrong preparation prevented” in day shift could have resulted in an under-dosing error of 1 to 8
units, depending on the algorithm ordered (see Appendix C, Figure C1). Chi-square tests of
independence showed that there were no significant differences between the two shifts.
Table 7
Frequencies of the Outcome Measures PREVENTED Between the Day Shift and Night Shift
During the Double-Checking Phase, “Errors Prevented” Cards
PREVENTED
Outcome Measure

Day shift
(N = 298)

Night shift
(N = 160)

c2

df

p Value

Inappropriate omission prevented?
Yes

0

0

---

---

---

Over-dosing prevented?
Yes

2 (0.7%)

2 (1.3%)

---

---

Under-dosing prevented?
Yes

0

0

---

---

Wrong preparation prevented?
Yes

1b (0.3%)

0

---

---

No errors prevented?
Yes

295 (99%)

158 (98.8%)

---

---

a

.614
---

a

1.000

a

1.000

Note. aUsing two-sided Fisher’s exact test. bThe “Errors Prevented Form” in this instance had
the comment: “Blood sugar 240 but RN wrote 204 on flowsheet; discovered with double-check.”
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Differences in outcome measures between the single and double-checking groups.
Table 8 provides a comparison of how often each of the outcome error types occurred during the
double-checking and the single-checking phases. Note that no subcutaneous insulin-related
MIDAS risk management reports and no “Self-Report of Wrong Preparation Error” forms (see
Appendix D, Figure D3) were filed during either phase of the pilot study. Although the doublechecking group had more “any one error” (10.9%, n = 81) than the single-checking group (9.3%,
n = 73), this was not a significant difference (c2 [1] = 1.191, p = .275). Moreover, between the
two checking groups, there was no significant difference in the “over-dosed” (p = .207, Fisher’s
two-sided exact test), “under-dosed” (c2 [1] = .533, p = .465) and “wrong preparation” errors (p
= 1.000, Fisher’s two-sided exact test). However, among the administration errors, the doublechecking group had significantly (c2 [1] = 7.635, p = .006) more “wrong-time” errors (33.5%, n
= 52) than the single-checking group (20.9%, n = 47),
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Table 8
Frequency of Errors Between the Single and Double-Checking Groups, eMAR audits
Outcome Measure

Double-checking
group (n)

Single-checking
group (n)

c2

df

p Value

Any one error?
Yes
Total (N)

10.9% (81)
740

9.3% (73)
788

1.191

1

.275

Administration error
Wrong time?
Yes
Total (N)

33.5% (52)
155

20.9% (47)
225

7.635

1

.006

Over-dosed?
Yes
Total (N)

1.6% (7)
450

0.6% (3)
496

---

---

Under-dosed?
Yes
Total (N)

1.8% (8)
451

1.2% (6)
499

.533

1

Wrong BG charted?
Yes
Total (N)

2% (15)
740

2% (16)
781

.001

1

Wrong preparation?
Yes
Total (N)

0.2% (1)
458

0.4% (2)
502

---

---

1.1% (3)
282

1.4% (4)
286

---

---

Inappropriate
omission?
Yes
Total (N)

a

.207

.465

.976

a

1.000

a

1.000

Note. eMAR: electronic medication administration record; n = sample; N = total sample; BG =
blood glucose.
a
Using two-sided Fisher’s exact test.
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Differences in the time lapse (in minutes) among isolation types. There was a
significant difference in the length of the time lapse from BG check to insulin administration for
at least one of the isolation types (F 3, 376= 2.730, p = .044). A Tukey’s honestly significantly
difference (HSD) post-hoc test revealed that the significant time difference (p = .043) was
between the enteric (C. difficile)—which took an average of 12.38 (± 16.016) minutes—and the
droplet precaution type—which unexpectedly took longer—at an average of 48.10 (± 53.507)
minutes. However, when an independent samples t-test was performed to compare the mean
time lapse between the enteric and droplet isolation types, with equal variances not assumed,
there was not a significant difference (t9.679= 2.073, p = .066). These unexpected results could
be due to the skewness of the data set in these groups, especially of the droplet isolation data set
that is skewed right (Figure 1).

Figure 1. Data set boxplots for isolation type and time lapse, where “iso” 2 is the code for
enteric precautions, 3 is for contact, 5 is for droplet, and 6 is for none; the contact with droplet
precaution type (coded as “4”) was omitted due to its small sample (n = 1). The labels for outlier
numbers identify case identification numbers from the whole data set (N = 1,528).
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Model significance and variance. Logistic regression tests were performed in order to
predict the probability of “any error” occurring from the check type, while controlling for other
predictor variables, such as age, gender, DM type, isolation type, and shift type. The single
categorical logistic regression model was significant (c2 [6] = 36.883, p < .001). However, only
between 2.4% (Cox & Snell R2) to 5% (Nagelkerke R2) of the variance in the dependent variable
(i.e., “any one error”) can be explained by the independent variables (i.e., check type, age,
gender, DM type, isolation type, and shift type), which means that at least 95% of the variation
was a result of something other than the relationship studied, perhaps of variables not examined
in the study (Grove, Gray, & Burns, 2015). The multiple categorical logistic regression was also
significant (c2 [60] = 167.127, p < .001) though only 10.4% (Cox & Snell R2) to 21.6%
(Nagelkerke R2) of the variance in the dependent variable (i.e., “any one error”) can be explained
by the independent variables (i.e., check type, age, gender, DM type, isolation type, and shift
type). Therefore, in both cases, it can be concluded that the check type, which was one of the
independent variables, did not contribute a significant effect to the likelihood that a medication
error would occur.
Implementation Observations
The most challenging part of the implementation was the preparation period—where the
PI met with Sub-ICU RNs individually and in small groups to brief them about the pilot
procedures and obtain their signatures acknowledging their understanding. Because there were
about 50 RNs who needed to be seen, it was challenging to meet all of them at the same time,
requiring multiple visits during the day and night shifts. When briefed on the correct calculation
method for insulin when patient parameters fell outside the dosing sliding scale tables, many
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Sub-ICU RNs verbalized their unawareness about their option to use the algorithm ratios (see
Appendix C, Figure C1) that were explicitly stated within the eMAR insulin task.
The pilot project itself was accepted among Sub-ICU RNs with enthusiasm--some of
them verbalized their curiosity over the end results, especially those who have experienced
giving subcutaneous insulin without the requirement to perform an IDC prior to administration.
Some of them verbalized excitement over the temporary permission to single-check. However,
there were some RNs who did not initially participate in single-checking (i.e., they were still
entering other RN’s names, instead of the PI’s, for the co-signature field in the eMAR insulin
task). When reminded that they could do so if they decided to participate, some of them
verbalized having missed the multiple email and early shift “huddle” announcements that the
single-checking period had started.
With the Sub-ICU charge RNs’ help, announcements were made on a regular basis to
remind the staff nurses that the single-checking period had started. As a result, more Sub-ICU
RNs participated in single-checking. However, a few floating RNs also participated, possibly as
an unintended consequence of these announcements. This required the PI to exclude those
insulin opportunities from the sample and immediately communicate with these RNs about their
ineligibility to participate in those insulin opportunities. After the end of the single-checking
period, which was also the end of the pilot study, a Sub-ICU RN continued to single-check,
which also prompted the PI to immediately communicate to the RN and remind the rest of SubICU that the pilot study had ended.
While performing the audits early in the pilot study (during the double-checking phase),
the PI identified an extraneous variable, that some RNs incorrectly documented the BG within
the eMAR insulin task. This prompted the PI to add “Wrong BG charted” to the outcome
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measures although tracking of this outcome measure was not initially planned. Moreover, the PI
realized that there was no automated checkpoint process in place to prevent the wrong multidose
single patient-use insulin pen from being used on the wrong patient. The only countermeasure to
this preparation error was the requirement for nurses to manually affix a patient label on the
insulin pen upon withdrawing it from the Pyxis automated dispensing medication cabinet; even
then, the patient label itself was not linked to the insulin pen nor did it have a barcode that was
recognizable by the eMAR.
Finally, although the PI initially decided to use the “Errors Prevented Form” (see
Appendix D, Figure D1) as the main method to track outcome measures during the doublechecking phase, the PI later identified another extraneous variable. Not all participating SubICU RNs were completing these forms every time, limiting the interpretation of the “Errors
Prevented Form” data findings. “Wrong-time” errors could not be thoroughly tracked, also,
which was the error most frequently observed in the Modic et al. study (2016). Additionally, the
assessment form was designed for two people to complete and hence was not feasible for RNs to
use during the single-checking phase. Therefore, in order to use an error assessment method that
could be consistently implemented during both double-checking and single-checking phases, the
PI decided to use eMAR chart audits as the main data source.
Impact of the Project
The aim of this study was to investigate whether the current practice (of requiring an
independent double-check [IDC] prior to subcutaneous insulin administration) at the hospital is
still consistent with the most current evidence. Because there is limited literature on the
effectiveness of IDC in reducing subcutaneous insulin-related medication errors, this project may
further contribute to the developing body of knowledge on this topic and could offer a
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reproducible model for future studies. Lessons learned from this project and recommendations
for future studies will be discussed in the next chapter.
With the results of this evidence-based practice project, practitioners and hospital
policymakers where the pilot study was performed can appraise additional evidence and decide if
an IDC should continue to be required of nurses prior to subcutaneous insulin administration
with this select patient population. (Note: Approximately five months after the pilot study
ended, in late April 2018, the hospital where the study was performed started using its affiliated
hospitals’ EHR. This prompted the hospital to allow its RNs to single-check prior to
administering subcutaneous insulin [U-100] to adult patients, to align with its affiliated hospitals’
single-checking policies.)
Summary
This chapter provided details on the results of the pilot study’s double and singlechecking phases. It explained the type of data that were collected, analyzed, and compared.
Methods of analysis and their rationales were reviewed and further explained. Findings were
presented in tables, figures, and in narrative. Interpretations of the findings were also postulated.
More importantly, this chapter answered the first study question: Although there was no
significant difference in the “any one error” rate between the double-checking and the singlechecking groups (c2 [1] = 1.191, p = .275), the double-checking group had significantly more
“wrong-time” errors than the single-checking group (c2 [1] = 7.635, p = .006). This chapter also
answered the second study question: Although there was no significant relationship between the
checking type and the likelihood of error occurring (r = .002, p = .942), there was a significant
negative relationship, between the shift type and the likelihood of error occurring (i.e., there was
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less likelihood of error occurring in night shift; r = -.052, p = .042). Chi-square tests revealed
that the day shift had significantly more “any one error” (c2 [1] = 16.057, p < .001) and “wrongtime” errors (c2 [1] = 36.718, p < .001) than the night shift.
Finally, observations from the study’s implementation were discussed. The impact of the
project on the agency’s local community was also considered. The next and final chapter will
offer possible conclusions drawn from the project, further discuss implications for nursing
practice, and make future recommendations.
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Chapter 5
Conclusion
The traditionally supported practice of nurses double checking subcutaneous insulin
before administration, albeit non-evidence-based, poses a clinical problem by imposing an
unnecessary demand on nurses’ workload, which places an obstacle to their timely
administration of subcutaneous insulin. This may induce financial loss to the hospital due to
reduced nursing productivity secondary to an inefficient patient care flow process and nurse
overtime wages. This may also lead to wrong-time (late) medication administration errors that
may place patients at risk for hypoglycemia, which is seen in insulin stacking—the practice of
administering additional doses of insulin before a previous dose of insulin has had its full effect
(Heise & Meneghini, 2014). These factors make this issue a priority for health care
organizations and thus the results of this study have important nursing implications.
Nursing Implications
There was no significant difference in the “any one error” rate between the doublechecking and the single-checking groups (c2 [1] = 1.191, p = .275), which implies that the
significantly longer process of double-checking (t253= 2.931, p = .004)—that took an average of
11.7 minutes longer than single-checking—did not significantly decrease “any one error” rates.
The double-checking group showed significantly (c2 [1] = 7.635, p = .006) more “wrong-time”
errors (33.5%, n = 52) than the single-checking group (20.9%, n = 47). Furthermore, although
double-checking was initially theorized by ISMP and TJC to reduce serious medication errors,
especially over-dosing and wrong-preparation errors (Cohen et al., 1998; The Joint Commission,
1999), the results of this study showed that there was no significant difference in the “over-
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dosed” (p = .207, Fisher’s two-sided exact test) and “wrong preparation” errors (p = 1.000,
Fisher’s two-sided exact test) between the double-checking and single-checking groups.
Because double-checking did not prevent the most prevalent subcutaneous insulin-related error
type—which was “wrong-time” errors—but instead was significantly associated with it, high
reliability health care organizations must focus on re-constructing the system to reduce nurses’
workload and subcutaneous insulin administration delays, rather than enforcing a timeconsuming verification practice that is not based on current evidence.
Strengths
This study’s findings are consistent with those of a recent similar study (Modic et al.,
2016), most relevant to this project and parts of which were replicated in this study. The finding
that there was no significant difference in the “any one error” rate between the double-checking
and single-checking groups was consistent with the study findings of Modic and colleagues.
Moreover, “wrong-time” errors were identified to be the most prevalent error in both studies.
Even though significant differences between the control and experimental groups of this
project were determined by a p value set at £ .05, the risk of type I “false positive” errors is still
low when interpreting the significant results that have a p value of < .01, such as the significantly
longer process of double-checking (t253= 2.931, p = .004) and the more frequent occurrence of
“wrong-time” errors during double-checking (c2 [1] = 7.635, p = .006). The risk of type II “false
negative” errors was also controlled by obtaining a large sample (N = 1,528).
Limitations
Although this study had a large sample, it is not without limitations. For example, it only
included high acuity patients in a single unit at an acute care hospital, making the results less
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generalizable to other settings. Additionally, because every age—including outliers—was listed
instead of grouped in ranges, this could limit the interpretation of the significant positive
relationship found between age and the likelihood of error occurring (r = .061, p = .017).
Another limitation stems from the logistic regression tests that showed at least 95% of the
variance (single categorical) and approximately at least 80% of the variance (multiple
categorical) in the dependent variable (i.e., “any one error”) cannot be explained by the
independent variables (i.e., check type, age, gender, DM type, isolation type, and shift type).
This means that the unexplained variance could be due to variables that were not examined in the
study. It is worth noting that among the variables omitted in this study, but included in the study
by Modic et al. (2016), was the nurse license type (registered nurse versus practical nurse).
Modic and colleagues, hypothesizing that different types of nurses could have had routines that
led to a higher tendency of errors, collected and controlled for the type of nurse. Future studies
may need to explore how to measure and control for nurse demographics, without sacrificing
anonymity and confidentiality principles.
Lastly, completion of the “Errors Prevented Form” during the double-checking phase
may have contributed to the time lapse between BG check to insulin administration. Completion
of the form was an added step to the established double-checking process at the unit where the
study took place. Future replication studies need to take into consideration the aforementioned
limitations of this study and make every attempt to control for both extraneous and confounding
variables.
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Recommendations for the Future
Although there was not a significant relationship between the checking type and the
likelihood of error (r = .002, p = .942), the results showed that there was a significant negative
correlation between the shift type and the likelihood of error occurring—that there was less
likelihood of error in night shift than the day shift (r = -.052, p = .042). The day shift had
significantly more “any one error” (c2 [1] = 16.057, p < .001) and “wrong-time” errors (c2 [1] =
36.718, p < .001) than the night shift. Further study is recommended to explore factors that may
contribute to the higher likelihood of error during the day shift.
Additionally, although Table 7 shows that there were no significant differences in the
error types (measured through the “Errors Prevented Form” tallies) between the two shifts, note
that the “wrong preparation prevented” in day shift associated with the wrong blood glucose
(BG) charted could have resulted in an under-dosing error of 1 to 8 units, depending on the
algorithm ordered (see Appendix C, Figure C1). Moreover, even though there was not a
significant difference in the “wrong BG charted” error in between the double-checking and
single-checking groups (c2 [1] = .001, p = .976), innovative solutions must be explored to
prevent nurses from administering the wrong dose based on the wrong BG charted. For
example, Hamilton and Morris (2014) built an effective solution to reduce medication errors
related to continuous heparin infusion dosing at the Cleveland Clinic by developing an
automated heparin dose calculator within the electronic health record (EHR).
It was also determined that there was no automated checkpoint process in place to
prevent the wrong multidose single-use insulin pen from being used on the wrong patient, apart
from requiring a manual check of the nurse-affixed patient label. Such a preparation error could
expose patients to bloodborne infections. Therefore, further investigation is needed to determine

INDEPENDENT DOUBLE-CHECKS AND SUBCUTANEOUS INSULIN

56

what automated checkpoint processes are in place at other high-reliability organizations (HRO)
to prevent this type of preparation error.
With the projected rise of diabetes prevalence and subsequent increase in the use of
subcutaneous insulin in the acute care setting over the next few decades, health care
organizations are encouraged to take a systems approach in mitigating medication errors. This
can be accomplished by shifting focus from enforcing time-consuming verification processes
prior to performing high-frequency tasks, such as subcutaneous insulin administration, to
maximizing system barriers that minimize nurses’ error-provoking conditions—that is, by
reducing the time pressure that heavily weighs on nurses’ workload. These proposed
countermeasures are based on the premise that “though we cannot change the human condition,
we can change the conditions under which humans work” (Reason, 2000, p. 768).
Hospital policymakers need to be aware of the limitations documented in the literature
related to independent double-checking. In an effort to progress the institution toward a safe,
high-reliability organization (HRO), organizations must recognize that though “human
variability is a force to harness in averting errors” leaders must also “work hard to focus that
variability and…constantly [be] preoccupied with the possibility of failure” (Reason, 2000).
HROs need to consider accomplishing this through a systems approach where those at the bluntend of errors (i.e., those in managerial or policy-making positions) are aware of the need to
modify the conditions under which those at the sharp-end work (i.e., frontline workers). A
hospital organization that seeks to be an HRO must recognize that to err is naturally human and
that with a systems approach, rather than relying on double-checking techniques that are
contingent on its fallible front-line nurses, minimizing the factors that could provoke their errors
would be a better approach to averting them.
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The Iowa Model

Figure A1. The Iowa Model (1998) in detail. Used/Reprinted with permission from the
University of Iowa Hospitals and Clinics. Copyright 1998. For permission to use or reproduce
the model, please contact the University of Iowa Hospitals and Clinics at (319) 384-9098.
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Appendix B
IRB Approval Documents
The approved study protocol (dated October 25, 2017), with hospital information censored
(substitute the word ‘hospital’), may be accessed through clicking or copying/pasting this link
onto the browser’s address bar: https://www.dropbox.com/s/able1xog45d3nwh/Protocol version
dated 25Oct2017 privacy mode.tiff?dl=0

Figure B1. The study hospital’s Institutional Review Board (IRB) approval letter.
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Appendix C
Pre-pilot Briefing Sessions
Sub-ICU RNs were asked to calculate the appropriate subcutaneous insulin aspart (Novolog®)
dose in three scenarios, with these patient parameters:

(1) Patient ate 130 grams of carbohydrates (CHO) for dinner, had blood glucose (BG) of 90
mg/dL before dinner, and had algorithm A ordered for CHO coverage. (Answer: 6 units)

(2) Patient ate 125 grams of carbohydrates (CHO) for dinner, had BG of 90 mg/dL before dinner,
and had algorithm A ordered for CHO coverage. (Answer: 7 units)

(3) Patient did not eat lunch due to a nothing by mouth (NPO) order but is receiving
methylprednisolone (Solu-medrol) intravenously. His noon BG was 410 mg/dL; second recheck
yielded 405 mg/dL. Algorithm B was ordered for correction. (Answer: 13 units, instead of the
otherwise correct 14 units. The hospital’s diabetes educator instructed not to exceed the
maximum number of units when patient parameters are outside the yellow-and-white correction
dosing table. For example, though the BG were more than 400 mg/dL, the RN should not give
more than 9 units [algorithm A], 13 units [algorithm B], 26 units [algorithm C], or 52 units
[algorithm D], unless the doctor orders otherwise.)
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Figure C1. A pre-printed copy of the hospital’s subcutaneous insulin sliding scale tables and
algorithm ratios that Sub-ICU RNs referred to during the briefing sessions. These tables and
ratios were available for immediate viewing within the insulin eMAR task window.
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Appendix D
Tools Used for the Pilot’s Data Collection
Access the four-page pilot manual through this link (if hyperlink does not work, copy and paste
the link onto web browser address bar): https://www.dropbox.com/s/sqx87cvfamolcod/Pilot
MANUAL for RNs privacy mode.tiff?dl=0

Figure D1. A blank “Errors Prevented” form (9 cm x 14 cm), that was made available to the
Sub-ICU RNs to report prevented errors during the double-checking phase, with the PI’s contact
number censored.
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Figure D2. The locked red drop box for the preprinted “Errors Prevented” forms during the
double-checking phase and the “Self-Report of Wrong Preparation Error” forms during the
single-checking phase.

Figure D3. A blank “Self-Report of Wrong Preparation Error” form that was available for the
Sub-ICU RN to report wrong preparation errors during the single-checking phase of the pilot
study.
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Figure D4. A template of Worksheet 1 stored in the PI’s hospital IT-generated and secured
computer directory. VAN = visit account number; DM = diabetes mellitus; iso = isolation
precaution type; BG = blood glucose.
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Appendix E
Certificates from Human Subjects Protection Training

Figure E1. Certificate proof of the principal investigator’s (PI) completion of the “Protecting
Human Research Participants” course provided by the National Institutes of Health (NIH).

Figure E2. Certificate proof of the principal investigator’s (PI) completion of the “Biomedical
Research” course provided by the Collaborative Institutional Training Initiative (CITI) program.
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Figure E3. Certificate proof of the principal investigator’s (PI) completion of the “Conflicts of
Interest” course provided by the Collaborative Institutional Training Initiative (CITI) program.

Figure E4. Certificate proof of the principal investigator’s (PI) completion of the “Good
Clinical Practice” course provided by the Collaborative Institutional Training Initiative (CITI)
program.

